Gameto: Funding, Investors & Team (Oct 2026)
Gameto is a biotechnology company focused on revolutionizing women's reproductive health through the development of innovative therapies. They aim to address the lack of effective treatment options for various female health conditions by using advanced scientific techniques. Through cellular engineering, Gameto has created female reproductive cell lines that closely resemble natural cells, enabling them to develop new therapeutic solutions. Their initial program, Fertilo, aims to enhance the outcomes of IVF and egg freezing procedures. In addition, they are working on developing an organoid of the female reproductive system called Deovo, as well as a cell-based therapy for primary ovarian insufficiency and menopause called Ameno. Gameto's team is dedicated to pushing the boundaries of medical technology to improve the lives of women everywhere.
Gameto has raised $114M across 4 funding rounds on record, the most recent a Series C of $44.0M announced in Aug 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gameto Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Gameto Funding Rounds
Gameto raised $20.0M in a Series A announced in Jan 2022.
8 months later, an undisclosed round of $17.0M was announced in Sep 2022.
1.7 years later, a Series B of $33.0M was announced in May 2024.
1.3 years later, a Series C of $44.0M was announced in Aug 2025.
Gameto Founders and Leadership Team
Contact details for the Gameto team: 1 of 3 have an email address on file.
Start 14-day free trial →Gameto Funding Compared to Other Biotechnology Startups
Gameto's latest round of $44.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gameto in Biotechnology and New York
Companies Similar to Gameto
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Gameto Funding FAQs
What does Gameto do?
Gameto is a biotechnology company focused on revolutionizing women's reproductive health through the development of innovative therapies. They aim to address the lack of effective treatment options for various female health conditions by using advanced scientific techniques. Through cellular engineering, Gameto has created female reproductive cell lines that closely resemble natural cells, enabling them to develop new therapeutic solutions. Their initial program, Fertilo, aims to enhance the outcomes of IVF and egg freezing procedures. In addition, they are working on developing an organoid of the female reproductive system called Deovo, as well as a cell-based therapy for primary ovarian insufficiency and menopause called Ameno. Gameto's team is dedicated to pushing the boundaries of medical technology to improve the lives of women everywhere.
How much funding has Gameto raised?
Gameto has raised $114M across 4 rounds on record. The most recent is a Series C of $44.0M announced in Aug 2025.
When did Gameto last raise funding?
Gameto's most recent funding round on record is a Series C of $44.0M, announced in Aug 2025.
Who founded Gameto?
FundedIQ lists Martin Varsavsky (Founder), Pranam Chatterjee (Founder) at Gameto.
Who is the CEO of Gameto?
Dina Radenkovic is listed as CEO at Gameto.
Where is Gameto headquartered?
Gameto is based in New York, New York, United States.
How many employees does Gameto have?
Gameto is in the 11-50 employee band.
How does Gameto's funding compare to other Biotechnology startups?
Gameto's latest round of $44.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Gameto Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gameto is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.